These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6206579)

  • 1. [Hemostasis in untreated acute leukemia. II. Natural inhibitors: biological and immunological activity. Immunologic variation of antithrombin III].
    Kordich L; Sassetti B; Lago O
    Sangre (Barc); 1984; 29(2):133-40. PubMed ID: 6206579
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of the determination of thrombin-antithrombin-III complexes in hypercoagulability states].
    García Avello A; García Frade A; Sureda JL; Torrado MC
    Sangre (Barc); 1991 Apr; 36(2):163. PubMed ID: 1866654
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma fibronectin in acute myeloid leukemia].
    García Frade LJ; García Avello A; Obispo T; Alava I; Odriozola J; Cesar J; Pardo A; Navarro JL
    Sangre (Barc); 1984; 29(4-A):376-83. PubMed ID: 6594781
    [No Abstract]   [Full Text] [Related]  

  • 4. [Several components of plasma hemostasis in patients with suppurative processes in the abdominal cavity].
    Markova OA; Platonova TK; Khvatov VB
    Klin Med (Mosk); 1992 Feb; 70(2):91-3. PubMed ID: 1380586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Total antithrombin activity in healthy newborn infants].
    Jiménez R; Navarrete M; Trejos R; Mora LA; Jiménez E
    Bol Med Hosp Infant Mex; 1982 Jun; 39(6):405-8. PubMed ID: 6180759
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein C and antithrombin III in children with acute leukemia.
    Atlihan F; Karakaş Z; Batun S
    Turk J Pediatr; 1993; 35(1):45-51. PubMed ID: 8236517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loss of inhibitors of the blood coagulation system in protein-losing enteropathy (author's transl)].
    Muntean W; Rossipal E
    Klin Padiatr; 1979 Jan; 191(1):20-3. PubMed ID: 310494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of the natural inhibitors to coagulation and fibrinolysis in cases of renal diseases (author's transl)].
    Nakamura K; Kazama M
    Rinsho Ketsueki; 1978 Jul; 19(7):934-9. PubMed ID: 81328
    [No Abstract]   [Full Text] [Related]  

  • 10. The behavior of antithrombin III, alpha 2 macroglobulin, and alpha 1 antitrypsin during cardiopulmonary bypass.
    Pickering NJ; Brody JI; Fink GB; Finnegan JO; Ablaza S
    Am J Clin Pathol; 1983 Oct; 80(4):459-64. PubMed ID: 6194683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitors of coagulation and fibrinolysis in diabetics].
    Tóthová E; Mechír J; Mudronová B; Petrásová D
    Vnitr Lek; 1988 Jun; 34(6):558-63. PubMed ID: 2457985
    [No Abstract]   [Full Text] [Related]  

  • 12. [Relationship between antiplasmin capacity and concentration of alpha 2-plasmin inhibitor, alpha 2-macroglobulin, alpha 1-antitrypsin, antithrombin III or C1-inactivator in plasma of patients with transient ischemic attacks (author's transl)].
    Matsuda T; Seki T; Miura R; Ogawara M; Yokouchi M; Yamanouchi H
    Rinsho Byori; 1980 Mar; 28(3):261-4. PubMed ID: 6154815
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on physiological inhibitors of coagulation and fibrinolysis in hepatobiliary diseases and acute pancreatitis (author's transl)].
    Yoshimura R; Satake K
    Rinsho Ketsueki; 1978 Jul; 19(7):927-33. PubMed ID: 81327
    [No Abstract]   [Full Text] [Related]  

  • 14. Disturbances of hemostasis in acute myeloblastic leukemia.
    Rosner F; Dobbs JV; Ritz ND; Lee SL
    Acta Haematol; 1970; 43(2):65-72. PubMed ID: 4986192
    [No Abstract]   [Full Text] [Related]  

  • 15. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alpha macroglobulins and alpha 1-antitrypsin levels in patients with acute myeloblastic leukemia].
    Kłoczko J; Wojtukiewicz M; Bielawiec M; Borowska M; Cymek B
    Pol Arch Med Wewn; 1987; 77(1-2):10-5. PubMed ID: 2484457
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antithrombin III and its role in normal and pathological hemostasis].
    Bŭchvarova V; Doĭchinov A; Angelova N
    Vutr Boles; 1981; 20(6):34-8. PubMed ID: 7039127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of natural clotting and fibrinolytic inhibitors in collagen and collagen like diseases (author's transl)].
    Oguri T; Hosoi A
    Rinsho Ketsueki; 1978 Jul; 19(7):940-6. PubMed ID: 81329
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of some blood coagulation parameters in angiographically documented coronary arteriosclerosis].
    Panizza P; Majolino I; Nalli G; Mussini A
    Haematologica; 1981 Dec; 66(6):768-78. PubMed ID: 6175552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.